Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment.
Xiao-Xiao FuJin WangHua-Ying CaiHong JiangJin-Zhan JiangHao-Hao ChenShu HanPublished in: Journal of inflammation research (2022)
Our study suggests that C16+Ang-1 can compensate for the shortcomings of levodopa, improve the CNS microenvironment, and ameliorate the effects of levodopa. This treatment strategy could be developed as a combinatorial therapeutic in the future.